Literature DB >> 24262196

Modeling Lewy pathology propagation in Parkinson's disease.

Kelvin C Luk1, Virginia M-Y Lee.   

Abstract

Lewy bodies (LBs) and Lewy neurites (LNs), comprised of alpha-synuclein (aSyn), are intraneuronal inclusions that characterize Parkinson's disease. Although the association between the extent of Lewy pathology and clinical symptoms is well established, how these proteinaceous deposits originate and target selectively vulnerable cell populations is unknown. Our knowledge of their role in PD pathogenesis is also limited. Here, we summarize recent findings demonstrating this pathology can be experimentally transmitted between animals by misfolded forms of aSyn that are capable of initiating and inducing LB and LN inclusion formation through a self-propagating mechanism reminiscent of prions. "Seeded" LBs and LNs in animal models also spread to multiple connected nuclei in a predictable pattern, recapitulating a phenomenon observed during human PD progression, leading to the dysfunction and degeneration of afflicted neurons. These models provide new perspectives on how this and other misfolded proteins may contribute to neurodegeneration in human disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Parkinson's disease; Propagation; Protein misfolding; α-Synuclein

Mesh:

Substances:

Year:  2014        PMID: 24262196      PMCID: PMC4034060          DOI: 10.1016/S1353-8020(13)70022-1

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

Review 1.  Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen.

Authors:  H Braak; U Rüb; W P Gai; K Del Tredici
Journal:  J Neural Transm (Vienna)       Date:  2003-05       Impact factor: 3.575

2.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

Review 3.  Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease.

Authors:  G M Halliday; K Del Tredici; H Braak
Journal:  J Neural Transm Suppl       Date:  2006

4.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

Authors:  A J Harding; G A Broe; G M Halliday
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

5.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal.

Authors:  L Maroteaux; J T Campanelli; R H Scheller
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

6.  Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations.

Authors:  Wenxue Li; Neva West; Emanuela Colla; Olga Pletnikova; Juan C Troncoso; Laura Marsh; Ted M Dawson; Pekka Jäkälä; Tobias Hartmann; Donald L Price; Michael K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

7.  Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.

Authors:  Masato Hasegawa; Hideo Fujiwara; Takashi Nonaka; Koichi Wakabayashi; Hitoshi Takahashi; Virginia M-Y Lee; John Q Trojanowski; David Mann; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

8.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

9.  Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

Authors:  Benoit I Giasson; John E Duda; Shawn M Quinn; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2002-05-16       Impact factor: 17.173

Review 10.  Genetics of Parkinson's disease and parkinsonism.

Authors:  John Hardy; Huaiban Cai; Mark R Cookson; Katrina Gwinn-Hardy; Andrew Singleton
Journal:  Ann Neurol       Date:  2006-10       Impact factor: 10.422

View more
  33 in total

1.  Synuclein expression in the lizard Anolis carolinensis.

Authors:  Mattia Toni; Carla Cioni; Federica De Angelis; Maria Carmela Bonaccorsi di Patti
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2016-07-08       Impact factor: 1.836

Review 2.  Parkinson's disease: what the model systems have taught us so far.

Authors:  Swagata Ghatak; Dorit Trudler; Nima Dolatabadi; Rajesh Ambasudhan
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

3.  Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Virginia M-Y Lee
Journal:  Nat Protoc       Date:  2014-08-14       Impact factor: 13.491

Review 4.  An update on the diagnosis and treatment of Parkinson disease.

Authors:  Philippe Rizek; Niraj Kumar; Mandar S Jog
Journal:  CMAJ       Date:  2016-05-24       Impact factor: 8.262

5.  Effects of Alpha-Synuclein on Primary Spinal Cord Neurons Associated with Apoptosis and CNTF Expression.

Authors:  Guo-Ying Feng; Jia Liu; You-Cui Wang; Zhen-Yu Wang; Yue Hu; Qing-Jie Xia; Yang Xu; Fei-Fei Shang; Mei-Rong Chen; Fang Wang; Xue Zhou; Ting-Hua Wang
Journal:  Cell Mol Neurobiol       Date:  2016-08-31       Impact factor: 5.046

6.  Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.

Authors:  A-L Mahul-Mellier; F Vercruysse; B Maco; N Ait-Bouziad; M De Roo; D Muller; H A Lashuel
Journal:  Cell Death Differ       Date:  2015-07-03       Impact factor: 15.828

Review 7.  The ongoing pursuit of neuroprotective therapies in Parkinson disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  Nat Rev Neurol       Date:  2014-12-02       Impact factor: 42.937

Review 8.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

9.  The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.

Authors:  Neda Shahmohammadibeni; Simin Rahimi-Aliabadi; Javad Jamshidi; Babak Emamalizadeh; Hossein Ali Shahmohammadibeni; Alireza Zare Bidoki; Haleh Akhavan-Niaki; Hajar Eftekhari; Shokoufeh Abdollahi; Mahmoud Shekari Khaniani; Mahnaz Shahmohammadibeni; Atena Fazeli; Marzieh Motallebi; Shaghayegh Taghavi; Azadeh Ahmadifard; Amir Ehtesham Shafiei Zarneh; Monavvar Andarva; Tahereh Dadkhah; Ehteram Khademi; Elham Alehabib; Mahnoosh Rahimi; Abbas Tafakhori; Minoo Atakhorrami; Hossein Darvish
Journal:  Neurol Sci       Date:  2016-01-05       Impact factor: 3.307

10.  Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb.

Authors:  Aishwarya S Kulkarni; Maria Del Mar Cortijo; Elizabeth R Roberts; Tamara L Suggs; Heather B Stover; José I Pena-Bravo; Jennifer A Steiner; Kelvin C Luk; Patrik Brundin; Daniel W Wesson
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.